|
|
READERS' QUESTIONNAIRE
|
|
Evaluation: agreement and criticism
|
|
|
SPOT ON
|
|
|
Manipulation of data in the PROactive-study suspected: Clinical benefit of pioglitazone (ACTOS) not proven
|
|
|
THERAPIES FROM A CRITICAL VIEW POINT
|
|
Is there a benefit of trastuzumab (HERCEPTIN) in adjuvant therapy of breast cancer?
CATIE-study: do newer "atypical" neuroleptics possess real advantages?
Antibiotic prophylaxis for chemotherapy induced neutropenia
|
|
|
IN BRIEF
|
|
Reducing intraocular pressure for prophylaxis and therapy of glaucoma
Conflicts of interest in clinical guidelines
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Hepatotoxicity of duloxetine (CYMBALTA, YENTREVE)
|
|
|
SIDE EFFECTS
|
|
Malformation induced by the SSRI paroxetine (e.g. SEROXAT) during pregnancy
Atomoxetine (STRATTERA) promotes suicidality
Tibolone (LIVIELLA) and stroke
|
|